Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.

Abstract:

:Resistance to chemotherapy remains a critical barrier to effective cancer treatment. Although cisplatin is one of the most commonly used chemotherapeutic agents in the treatment of non-small cell lung cancer (NSCLC), mechanisms of resistance to this drug are not fully understood. Here, we report a novel cisplatin-resistance mechanism involving SET Domain Containing 2 (SETD2), a histone H3 lysine 36 (H3K36) trimethyltransferase, and cAMP-responsive element-binding protein 1 (CREB1). A549 cells selected in vivo to give brain metastases exhibited cisplatin resistance and decreased expression of phosphorylated CREB1. Next-generation sequencing (NGS) analysis identified a missense mutation in SETD2 (p.T1171K), and we demonstrated that SETD2-mediated trimethylation of H3K36 (H3K36me3) and CREB1 phosphorylation are critical for cellular sensitivity to cisplatin. Moreover, we showed that suppression of SETD2 or CREB1 and ectopic expression of mutant SETD2 conferred cisplatin resistance through inhibition of H3K36me3 and ERK activation in NSCLC cells. Our results provide evidence that SETD2 and CREB1 contribute to cisplatin cytotoxicity via regulation of the ERK signaling pathway, and their inactivation may lead to cisplatin resistance.

journal_name

Oncogene

journal_title

Oncogene

authors

Kim IK,McCutcheon JN,Rao G,Liu SV,Pommier Y,Skrzypski M,Zhang YW,Giaccone G

doi

10.1038/s41388-018-0429-3

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

180-193

issue

2

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-018-0429-3

journal_volume

38

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Transcription activation mediated by chromosomal inversion in rat cells.

    abstract::To investigate the relationship between the local configuration of a gene and its level of expression, we constructed a rat cell line, Hy5, carrying a mutant polyomavirus middle T oncogene (pmt) whose overexpression converted the cells to the transformed state. The structure of the transgene was such that pmt was able...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: St-Onge L,Bastin M

    更新日期:1994-03-01 00:00:00

  • Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.

    abstract::The hyperactivated Wnt/β-catenin signaling acts as a switch to induce epithelial to mesenchymal transition and promote colorectal cancer. However, due to its essential role in gut homeostasis, therapeutic targeting of this pathway has proven challenging. Additionally, IL-6/Stat-3 signaling, activated by microbial tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.259

    authors: Ahmad R,Kumar B,Chen Z,Chen X,Müller D,Lele SM,Washington MK,Batra SK,Dhawan P,Singh AB

    更新日期:2017-11-23 00:00:00

  • SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.

    abstract::Liver metastasis remains a serious problem in the management of gastric cancer (GC). Our aims were to identify through transcriptome analysis a molecule that mediates hepatic metastasis in GC, and to evaluate its potential as a diagnostic marker and a therapeutic target. The effects of knocking out a relevant molecule...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0335-8

    authors: Kanda M,Tanaka H,Shimizu D,Miwa T,Umeda S,Tanaka C,Kobayashi D,Hattori N,Suenaga M,Hayashi M,Iwata N,Yamada S,Fujiwara M,Kodera Y

    更新日期:2018-09-01 00:00:00

  • LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.

    abstract::Liver tumor-initiating cells (TICs), the drivers for liver tumorigenesis, accounts for liver tumor initiation, metastasis, drug resistance and relapse. Wnt/β-catenin signaling pathway emerges as a critical modulator in liver TIC self-renewal. However, the molecular mechanism of Wnt/β-catenin initiation in liver tumori...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0203-6

    authors: Chen Z,Gao Y,Yao L,Liu Y,Huang L,Yan Z,Zhao W,Zhu P,Weng H

    更新日期:2018-06-01 00:00:00

  • Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells.

    abstract::Using Southern blot analysis of DNA from mouse-hamster somatic cell hybrids, we have mapped Lmyc and Bmyc, two members of the myc family of genes, to mouse chromosomes 4 and 2, respectively. Furthermore, we have compared the regulation of Lmyc and Bmyc expression under different growth conditions and during in vitro d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ingvarsson S,Sundaresan S,Jin P,Francke U,Asker C,Sümegi J,Klein G,Sejersen T

    更新日期:1988-12-01 00:00:00

  • Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells.

    abstract::Cell cycle checkpoints ensure genome integrity and are frequently compromised in human cancers. A therapeutic strategy being explored takes advantage of checkpoint defects in p53-deficient tumors in order to sensitize them to DNA-damaging agents by eliminating Chk1-mediated checkpoint responses. Using mouse models, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.84

    authors: Origanti S,Cai SR,Munir AZ,White LS,Piwnica-Worms H

    更新日期:2013-01-31 00:00:00

  • Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.

    abstract::Amplified in breast cancer 1 (AIB1) is a transcriptional coactivator for nuclear receptors and other transcription factors. AIB1 has an important role in malignancy of several cancers such as breast and prostate cancers. However, its involvement in human hepatocellular carcinoma (HCC) progression remains unclear. Here...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.90

    authors: Xu Y,Chen Q,Li W,Su X,Chen T,Liu Y,Zhao Y,Yu C

    更新日期:2010-06-10 00:00:00

  • Cancer whole-genome sequencing: present and future.

    abstract::Recent explosive advances in next-generation sequencing technology and computational approaches to massive data enable us to analyze a number of cancer genome profiles by whole-genome sequencing (WGS). To explore cancer genomic alterations and their diversity comprehensively, global and local cancer genome-sequencing ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.90

    authors: Nakagawa H,Wardell CP,Furuta M,Taniguchi H,Fujimoto A

    更新日期:2015-12-03 00:00:00

  • An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells.

    abstract::Tumors consistently mimic wound-generating chronic inflammation; however, why they do not heal like wounds with fibrotic scars remains unknown. The components of the tumor microenvironment, such as transforming growth factor β (TGF-β) and fibroblast growth factors (FGFs), may account for this phenomenon. Tumor formati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.512

    authors: Zhang HR,Wang XD,Yang X,Chen D,Hao J,Cao R,Wu XZ

    更新日期:2017-07-06 00:00:00

  • MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.

    abstract::Gastric cancer (GC) is one of the most common tumors and the molecular mechanism underlying its metastasis is still largely unclear. Here, we show that miR-25 was overexpressed in plasma and primary tumor tissues of GC patients with tumor node metastasis stage (III or IV) or lymph node metastasis. MiR-25 inhibition si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.214

    authors: Li BS,Zuo QF,Zhao YL,Xiao B,Zhuang Y,Mao XH,Wu C,Yang SM,Zeng H,Zou QM,Guo G

    更新日期:2015-05-14 00:00:00

  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

    abstract::Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0872-9

    authors: Yuan X,Larsson C,Xu D

    更新日期:2019-08-01 00:00:00

  • Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.

    abstract::Squamous cell carcinoma (SCC) cells of the head and neck specifically express collagenase-3 (matrix metalloproteinase-13 (MMP-13)), the expression of which correlates with their invasion capacity. Transforming growth factor-beta (TGF-beta) enhances MMP-13 and collagenase-1 (MMP-1) expression and invasion of SCC cells ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209291

    authors: Leivonen SK,Ala-Aho R,Koli K,Grénman R,Peltonen J,Kähäri VM

    更新日期:2006-04-27 00:00:00

  • Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription.

    abstract::The fibroblast growth factor-binding protein (FGF-BP) modulates FGF activity through binding and release from the extracellular matrix. Consequently, the expression of FGF-BP in certain tumor types is a rate-limiting regulator of FGF-mediated angiogenesis. FGF-BP is upregulated in squamous cell carcinoma by treatment ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204249

    authors: Harris VK,Kagan BL,Ray R,Coticchia CM,Liaudet-Coopman ED,Wellstein A,Tate Riegel A

    更新日期:2001-03-29 00:00:00

  • Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer.

    abstract::Non-small cell lung cancer remains a highly lethal malignancy. Using the tamoxifen inducible Hnf1b:CreERT2 (H) transgenic mouse crossed to the LsL-KrasG12D (K) transgenic mouse, we recently discovered that an Hnf1b positive cell type in the lung is sensitive to adenoma formation when expressing a mutant KrasG12D allel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1031-z

    authors: Singh K,Pruski MA,Polireddy K,Jones NC,Chen Q,Yao J,Dar WA,McAllister F,Ju C,Eltzschig HK,Younes M,Moran C,Karmouty-Quintana H,Ying H,Bailey JM

    更新日期:2020-01-01 00:00:00

  • Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.

    abstract::The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: De Benedetti VM,Radice P,Mondini P,Spatti G,Conti A,Illeni MT,Caligo MA,Cipollini G,Bevilaqua G,Pilotti S,Pierotti MA

    更新日期:1996-09-19 00:00:00

  • Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.

    abstract::Secreted frizzled related protein 1 (SFRP 1) is an antagonist of the transmembrane frizzled receptor, a component of the Wnt signaling pathway, and has been suggested to be a candidate tumor suppressor in several human malignancies. Since SFRP 1 is located at chromosome 8 p 11, where lung cancers also exhibit frequent...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208777

    authors: Fukui T,Kondo M,Ito G,Maeda O,Sato N,Yoshioka H,Yokoi K,Ueda Y,Shimokata K,Sekido Y

    更新日期:2005-09-15 00:00:00

  • Effects of hTERT on metal ion-induced genomic instability.

    abstract::There is currently a great interest in delayed chromosomal and other damaging effects of low-dose exposure to a variety of pollutants which appear collectively to act through induction of stress-response pathways related to oxidative stress and ageing. These have been studied mostly in the radiation field but evidence...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209399

    authors: Glaviano A,Nayak V,Cabuy E,Baird DM,Yin Z,Newson R,Ladon D,Rubio MA,Slijepcevic P,Lyng F,Mothersill C,Case CP

    更新日期:2006-06-08 00:00:00

  • miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.

    abstract::Non-small cell lung cancer (NSCLC) accounts for ∼80% of all lung cancers. Although some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.260

    authors: Acunzo M,Visone R,Romano G,Veronese A,Lovat F,Palmieri D,Bottoni A,Garofalo M,Gasparini P,Condorelli G,Chiariello M,Croce CM

    更新日期:2012-02-02 00:00:00

  • Towards a blueprint of the cell cycle.

    abstract::The understanding of the organisation of cell cycle events is of utmost importance to devise effective therapeutic strategies for cancer. In this article we gather evidences from the literature in support of a system model of the cell cycle, in which a growth-sensitive threshold controls entry into S phase and the seq...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204263

    authors: Alberghina L,Porro D,Cazzador L

    更新日期:2001-03-01 00:00:00

  • Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.

    abstract::Alu sequences are the most abundant short interspersed repeated elements in the human genome. Here we show that in a cell culture model of colorectal cancer (CRC) progression, we observe accumulation of Alu RNA that is associated with reduced DICER1 levels. Alu RNA induces epithelial-to-mesenchymal transition (EMT) by...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.369

    authors: Di Ruocco F,Basso V,Rivoire M,Mehlen P,Ambati J,De Falco S,Tarallo V

    更新日期:2018-02-01 00:00:00

  • TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.

    abstract::To achieve a better understanding of mechanisms that underlie hepatocarcinogenesis and to identify novel target molecules for diagnosis and therapy of hepatocellular carcinoma (HCC), we previously analysed gene-expression profiles of 20 HCC tissues on a cDNA microarray. Among the genes upregulated in the tumor tissues...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209517

    authors: Silva FP,Hamamoto R,Furukawa Y,Nakamura Y

    更新日期:2006-08-17 00:00:00

  • KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.

    abstract::Studies have reported that interactions between keratins (KRTs) and other proteins initiate signaling cascades that regulate cell migration, invasion, and metastasis. In the current study, we found that expression of KRT19 was specifically high in breast cancers and significantly correlated with their invasiveness. Mo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.221

    authors: Saha SK,Choi HY,Kim BW,Dayem AA,Yang GM,Kim KS,Yin YF,Cho SG

    更新日期:2017-01-19 00:00:00

  • Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation.

    abstract::The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210049

    authors: Hurley PJ,Wilsker D,Bunz F

    更新日期:2007-04-19 00:00:00

  • ATR mediates cisplatin resistance in a p53 genotype-specific manner.

    abstract::The protein kinase encoded by the ataxia telangiectasia and Rad3-related (ATR) gene is activated by DNA-damaging agents that are frequently used as anticancer therapeutics. Inhibition of ATR expression in cultured cancer cells has been demonstrated to increase sensitivity to chemotherapeutic drugs, including the DNA-c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.624

    authors: Sangster-Guity N,Conrad BH,Papadopoulos N,Bunz F

    更新日期:2011-06-02 00:00:00

  • Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.

    abstract::While 25% of human cancers harbor oncogenic Ras mutations, such mutations are not found in astrocytomas. We have previously demonstrated that the activation of receptor tyrosine kinases expressed by malignant human astrocytoma cells and specimens results in functional upregulation of the Ras signalling pathway and inc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203105

    authors: Feldkamp MM,Lau N,Guha A

    更新日期:1999-12-09 00:00:00

  • The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

    abstract::The MTG (Myeloid Translocation Gene) proteins are a family of novel transcriptional corepressors. We report that MTG16a, a protein isoform encoded by the MTG16 gene deranged by the t (16; 21) in myeloid malignancies, is targeted to the nucleolus. The amino acid sequence necessary for nucleolar localization was mapped ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205882

    authors: Hoogeveen AT,Rossetti S,Stoyanova V,Schonkeren J,Fenaroli A,Schiaffonati L,van Unen L,Sacchi N

    更新日期:2002-09-26 00:00:00

  • Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0902-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • Mode of action of trabectedin in myxoid liposarcomas.

    abstract::To elucidate the mechanisms behind the high sensitivity of myxoid/round cell liposarcoma (MRCL) to trabectedin and the suggested selectivity for specific subtypes, we have developed and characterized three MRCL xenografts, namely ML017, ML015 and ML004 differing for the break point of the fusion gene FUS-CHOP, respect...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.462

    authors: Di Giandomenico S,Frapolli R,Bello E,Uboldi S,Licandro SA,Marchini S,Beltrame L,Brich S,Mauro V,Tamborini E,Pilotti S,Casali PG,Grosso F,Sanfilippo R,Gronchi A,Mantovani R,Gatta R,Galmarini CM,Sousa-Faro JM,D'Incalc

    更新日期:2014-10-30 00:00:00

  • Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.

    abstract::Syndecan-1 is a heparan sulfate proteoglycan (HSPG) commonly upregulated in AIDS-related B lymphoid malignancies. Tat is the main HIV-1 transactivating factor that has a major role in the pathogenesis of AIDS-related lymphomas (ARL) by engaging heparan sulfate proteoglycans (HSPGs), chemokine receptors and integrins a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.420

    authors: Urbinati C,Grillo E,Chiodelli P,Tobia C,Caccuri F,Fiorentini S,David G,Rusnati M

    更新日期:2017-05-04 00:00:00

  • Induction of telomerase activity by UV-irradiation in Chinese hamster cells.

    abstract::Telomerase is a ribonucleoprotein whose activity has been detected in germline cells and in neoplastic and immortal cells. Telomerase compensates the telomere loss arising by the end replication problem by synthesizing telomeric repeats at the 3' end of the eukaryotic chromosomes. Telomerase is reactivated during canc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201327

    authors: Hande MP,Balajee AS,Natarajan AT

    更新日期:1997-10-02 00:00:00